NEW YORK, NY / ACCESSWIRE / November 9, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of eHealth, Inc. (EHTH) ("eHealth" or the "Company") (NASDAQ:EHTH). Investors who purchased eHealth shares are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/ehth.
The investigation concerns whether eHealth and certain of its officers and/or directors have violated federal securities laws.
On November 8, 2021, eHealth issued a press release announcing its financial results for the third quarter of 2021. Among other items, eHealth announced earnings per share and revenue that fell short of consensus estimates. eHealth also revised its full-year revenue guidance sharply downward, to a range of $535 million to $575 million, compared to previous guidance of $660 million to $700 million, and advised investors that it expected a GAAP net loss in the range of $43 million to $63 million compared to previous guidance of GAAP net income of $42 million to $57 million. On this news, eHealth's stock price fell $10.36 per share, or 25.59%, to close at $30.06 per share on November 8, 2021.
If you are aware of any facts relating to this investigation, or purchased eHealth shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/ehth. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]
SOURCE: Bronstein, Gewirtz & Grossman, LLC